The effectiveness and safety of immune checkpoint inhibitors in conversion or neoadjuvant therapy for hepatocellular carcinoma: a meta-analysis and systematic review
Abstract Background The adoption of immune checkpoint inhibitors in combination with tyrosine kinase inhibitors (TKIs) and/or local therapy, including transarterial chemoembolization (TACE) and hepatic arterial infusion chemotherapy (HAIC), has been utilized as neoadjuvant or conversion therapy for...
Sparad:
| Huvudupphov: | , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
BMC
2025-12-01
|
| Serie: | BMC Cancer |
| Ämnen: | |
| Länkar: | https://doi.org/10.1186/s12885-025-15449-2 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|